Of iniquitous burdens - cancer and summer
The World Health Organization's Global Status Report on Cancer 2026 highlights that cancer remains a significant financial and social burden globally, with 45% of affected individuals facing financial hardship. The report reveals stark inequities in access to cancer care, with survival rates for breast cancer at 87% in high-income countries compared to just 42% in low-income nations. Reliance’s Strand Life Sciences has received a patent for a blood-based early cancer detection platform, which could improve diagnosis rates significantly.